Frank T. Kolligs

Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

Armando Santoro, Lorenza Rimassa, Ivan Borbath et al. · The Lancet Oncology · 2012 · 549 citations

Second-line Treatment, Placebo-controlled Phase 2, Oncology +11

Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population

Anno Graser, P Stieber, Dorothea Nagel et al. · Gut · 2008 · 387 citations

Activation of AXIN2 Expression by β-Catenin-T Cell Factor

Janet Y. Leung, Frank T. Kolligs, Rong Wu et al. · Journal of Biological Chemistry · 2002 · 358 citations · Full text

Neoplastic Transformation of RK3E by Mutant β-Catenin Requires Deregulation of Tcf/Lef Transcription but Not Activation of c-<i>myc</i> Expression

Frank T. Kolligs, Gang Hu, Chi V. Dang et al. · Molecular and Cellular Biology · 1999 · 320 citations · Full text

Molecular Biology, Pathology, Tumor Biology +19

Transient activation of β-catenin signaling in cutaneous keratinocytes is sufficient to trigger the active growth phase of the hair cycle in mice

David Van Mater, Frank T. Kolligs, Andrzej A. Dlugosz et al. · Genes & Development · 2003 · 262 citations · Full text

Cell Proliferation, Dermatology, Tissue Development +16